Talphera

TLPHNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$52.684 M

$1.02 -3.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Talphera (TLPH) has a market capitalization of $52.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$14.3M

Loss-making

Shares outstanding

51,905,796

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#332Verrica PharmaceuticalsVRCA$53.4M
#333Heron TherapeuticsHRTX$52.8M
#334TalpheraTLPH$52.7M
#335Pliant TherapeuticsPLRX$50.5M
#336ApollomicsAPLM$49.5M

What if Talphera were worth as much as…

Open the what-if tool →

Gold $28.2T

$544,002.33

Per share 535,963× higher

Bitcoin $1.53T

$29,435.02

Per share 29,000× higher

Apple $5.02T

$96,632.42

Per share 95,204× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Talphera are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.